Page last updated: 2024-08-18

pyrroles and raltegravir potassium

pyrroles has been researched along with raltegravir potassium in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Al-Mawsawi, LQ; Dayam, R; Neamati, N	1
Barreca, ML; Chimirri, A; De Luca, L; Iraci, N	1
de Serres, M; Gould, E; Johnson, M; Kim, J; Lou, Y; Mayers, D; Pietropaolo, K; Piscitelli, S; White, S; Zhou, XJ	1
Blonk, M; Burger, D; Colbers, A; Schouwenberg, B; van Beek, M	1

Trials

2 trial(s) available for pyrroles and raltegravir potassium

Article	Year
Drug interaction profile for GSK2248761, a next generation non-nucleoside reverse transcriptase inhibitor. British journal of clinical pharmacology, 2012, Volume: 74, Issue:2 Topics: Adenine; Androstenes; Anti-HIV Agents; Atazanavir Sulfate; Atorvastatin; Contraceptives, Oral; Cross-Over Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Darunavir; Deoxycytidine; Double-Blind Method; Drug Combinations; Drug Interactions; Emtricitabine; Ethinyl Estradiol; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Least-Squares Analysis; Linear Models; Lopinavir; Male; Oligopeptides; Organophosphonates; Patient Safety; Phosphinic Acids; Pyridines; Pyrimidines; Pyrroles; Pyrrolidinones; Raltegravir Potassium; Reverse Transcriptase Inhibitors; Risk Assessment; Ritonavir; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Tenofovir	2012
Pharmacokinetic Drug-Drug Interaction Study Between Raltegravir and Atorvastatin 20 mg in Healthy Volunteers. Journal of acquired immune deficiency syndromes (1999), 2015, May-01, Volume: 69, Issue:1 Topics: Adolescent; Adult; Anti-HIV Agents; Anticholesteremic Agents; Area Under Curve; Atorvastatin; Cross-Over Studies; Drug Interactions; Female; Healthy Volunteers; Heptanoic Acids; Humans; Lipids; Male; Plasma; Pyrroles; Pyrrolidinones; Raltegravir Potassium; Time Factors; Young Adult	2015

Article

Year

Drug interaction profile for GSK2248761, a next generation non-nucleoside reverse transcriptase inhibitor.

British journal of clinical pharmacology, 2012, Volume: 74, Issue:2

Topics: Adenine; Androstenes; Anti-HIV Agents; Atazanavir Sulfate; Atorvastatin; Contraceptives, Oral; Cross-Over Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Darunavir; Deoxycytidine; Double-Blind Method; Drug Combinations; Drug Interactions; Emtricitabine; Ethinyl Estradiol; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Least-Squares Analysis; Linear Models; Lopinavir; Male; Oligopeptides; Organophosphonates; Patient Safety; Phosphinic Acids; Pyridines; Pyrimidines; Pyrroles; Pyrrolidinones; Raltegravir Potassium; Reverse Transcriptase Inhibitors; Risk Assessment; Ritonavir; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Tenofovir

2012

Pharmacokinetic Drug-Drug Interaction Study Between Raltegravir and Atorvastatin 20 mg in Healthy Volunteers.

Journal of acquired immune deficiency syndromes (1999), 2015, May-01, Volume: 69, Issue:1

Topics: Adolescent; Adult; Anti-HIV Agents; Anticholesteremic Agents; Area Under Curve; Atorvastatin; Cross-Over Studies; Drug Interactions; Female; Healthy Volunteers; Heptanoic Acids; Humans; Lipids; Male; Plasma; Pyrroles; Pyrrolidinones; Raltegravir Potassium; Time Factors; Young Adult

2015

Other Studies

2 other study(ies) available for pyrroles and raltegravir potassium

Article	Year
Substituted 2-pyrrolinone inhibitors of HIV-1 integrase. Bioorganic & medicinal chemistry letters, 2007, Nov-15, Volume: 17, Issue:22 Topics: Furans; HIV Integrase; HIV Integrase Inhibitors; Humans; Molecular Structure; Organic Chemicals; Pyrroles; Pyrrolidinones; Quinolones; Raltegravir Potassium; Triazoles	2007
Induced-fit docking approach provides insight into the binding mode and mechanism of action of HIV-1 integrase inhibitors. ChemMedChem, 2009, Volume: 4, Issue:9 Topics: Acetoacetates; Anti-HIV Agents; Binding Sites; Computer Simulation; Drug Design; Furans; HIV Integrase; HIV Integrase Inhibitors; Humans; Mutation; Naphthyridines; Pyrroles; Pyrrolidinones; Quinolones; Raltegravir Potassium; Triazoles	2009

Article

Year

Substituted 2-pyrrolinone inhibitors of HIV-1 integrase.

Bioorganic & medicinal chemistry letters, 2007, Nov-15, Volume: 17, Issue:22

Topics: Furans; HIV Integrase; HIV Integrase Inhibitors; Humans; Molecular Structure; Organic Chemicals; Pyrroles; Pyrrolidinones; Quinolones; Raltegravir Potassium; Triazoles

2007

Induced-fit docking approach provides insight into the binding mode and mechanism of action of HIV-1 integrase inhibitors.

ChemMedChem, 2009, Volume: 4, Issue:9

Topics: Acetoacetates; Anti-HIV Agents; Binding Sites; Computer Simulation; Drug Design; Furans; HIV Integrase; HIV Integrase Inhibitors; Humans; Mutation; Naphthyridines; Pyrroles; Pyrrolidinones; Quinolones; Raltegravir Potassium; Triazoles

2009